Is LYVLEE LIMITED FDA approved?

LYVLEE LIMITED holds 1 FDA-registered establishment in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are LYVLEE LIMITED's drugs manufactured?

The FDA register lists DORCHESTER. Registered operations: active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.

LYVLEE LIMITED

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: United Kingdom

Authorisation

Registered operations

Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
LYVLEE LIMITED	UNIT 12JKL, HYBRIS BUS, Hybris Business Park, Warmwell Road, Crossways, DORCHESTER, DT2 8BF, United Kingdom (GBR)	Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, Repackaging	3023829571216972894

Compare

Comparable companies in United Kingdom

PENN PHARMACEUTICALS LIMITED1 site · 24 NDC
BTG International Inc1 site · 10 NDC
Minteq U K LTD1 site · 7 NDC
Bespak HC Limited1 site · 5 NDC
Lofthouse of Fleetwood, Ltd.1 site · 5 NDC
Nicobrand Limited1 site · 5 NDC
Rosemont Pharmaceuticals Limited1 site · 5 NDC
Bio Products Laboratory Ltd1 site · 4 NDC
Macfarlan Smith Limited1 site · 4 NDC
Basildon Chemical Co., Ltd.1 site · 3 NDC

Enquiry

Common questions

Is LYVLEE LIMITED FDA approved?: LYVLEE LIMITED holds 1 FDA-registered establishment in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are LYVLEE LIMITED's drugs manufactured?: The FDA register lists DORCHESTER. Registered operations: active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.